As of Jun 29
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for StemCells Inc have a median target of 36.00, with a high estimate of 36.00 and a low estimate of 36.00. The median estimate represents a +8,430.81% increase from the last price of 0.42.
The current consensus among 1 polled investment analysts is to Hold stock in StemCells Inc. This rating has held steady since June, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.